Junlin QiaoChief Financial Officer

Junlin Qiao · Chief Financial Officer · China

From checking a supply record to explaining a service model

Chief financial officer

Luyanshu Diagnostic Services

Sector
Independent clinical laboratory services
Ownership
Founder majority with a minority financial investor
Company scale
RMB228 million revenue and RMB17 million operating profit in calendar 2025
Employees
410
Geography
China; three laboratories serving hospitals and clinics
Reporting to
Chief executive; executive invitee to board discussions
Team
27 finance colleagues through three managers
Financial scope
Reporting, treasury, procurement economics, planning and investment evaluation

Mandate

Make the financial support for dependable laboratory service understandable to management and directors.

Outcomes

  • Reframed a reagent renewal around supported consumption and minimum commitment
  • Included collection obligations in a clinic-pricing decision
  • Funded a defined overlap during an equipment transition

Decisions in context

I lead the financial account of three laboratories without assuming authority over their clinical work. The role includes reporting, funding and the financial evaluation of procurement and customer commitments. I work with the chief executive and laboratory leaders to make the service assumptions behind a proposal explicit before it reaches the board. Our founder shareholders and minority investor may place different weight on growth and returns, so I want them to begin with a shared understanding of the obligation. The cases on this site show where a lower minimum, a smaller customer scope or a more expensive transition became the better-supported choice. I attend board discussions as CFO and have no directorship. My responsibility is to prepare a recommendation that can be examined, including its disadvantages, while the directors retain their collective decision and qualified colleagues retain clinical authority.

Reason for the move

Current executive appointment; exploring one compatible external board contribution.

Group financial controller

Luyanshu Diagnostic Services

Sector
Multi-site diagnostic laboratory services
Ownership
Founder-controlled; minority financial investment introduced during the period
Company scale
Approximately RMB176 million annual revenue at period end
Employees
Three hundred and thirty at period end
Geography
China; three laboratory sites at period end
Reporting to
Chief financial officer
Team
Eighteen central and site-finance colleagues
Financial scope
Consolidated reporting, budgets, funding schedules and investment papers

Mandate

Provide a consistent financial explanation while retaining site-specific service and transition costs.

Outcomes

  • Separated temporary introduction costs from ongoing equipment economics
  • Coordinated site narratives with consolidated reporting
  • Prepared supported financial schedules for shareholder and lender review

Decisions in context

Group control required me to explain differences that a single site could previously discuss informally. Laboratories had different service mixes, equipment arrangements and customer requirements. I coordinated the close and planning process so that the consolidated result retained the material reasons for those differences. I also prepared financial schedules for investment and funding discussions, working with advisers on specialist accounting matters. The role made timing more prominent in my judgement. A project could have a supportable long-term case while requiring a costly introduction period, and a site comparison could be misleading if one laboratory was carrying that transition. My eighteen colleagues maintained the records and supporting explanations. I wanted a director reading the group paper to understand what had changed operationally before deciding whether a financial movement represented an enduring problem, a deliberate commitment or a temporary stage.

Reason for the move

Selected for the CFO appointment after coordinating the three-site financial record and shareholder reporting.

Commercial finance manager

Luyanshu Diagnostic Services

Sector
Laboratory services for institutional customers
Ownership
Privately held founder enterprise
Company scale
Approximately RMB112 million annual company revenue at period end
Employees
Two hundred and twenty at period end
Geography
China; two laboratories and their customer-service network
Reporting to
Chief financial officer; works with commercial director
Team
Five contract and cost analysts
Financial scope
Customer contribution, service-pricing analysis and contract forecasts

Mandate

Connect price recommendations with the service requirements described to customers.

Outcomes

  • Identified collection and support costs outside analytical price comparisons
  • Prepared customer scenarios using explicit activity assumptions
  • Distinguished commercial investment in a relationship from an apparent cost advantage

Decisions in context

Commercial finance taught me to ask what a customer meant by the service before discussing the price. A clinic group might require additional collections or support arrangements even when its analytical work looked familiar. I worked with the commercial director and operating colleagues to describe those obligations and compare alternatives. My team prepared contribution analyses and forecasts, but we did not decide clinical ordering or the laboratory's accepted procedures. The useful question was whether a proposed discount reflected a real operating difference or an assumption that had not been examined. Sometimes the company chose to support a relationship at a lower return for a stated commercial reason. I wanted that choice to be visible rather than concealed within an average cost. The experience helped me discuss difficult renewals without treating either finance or the relationship team as the sole owner of the decision.

Reason for the move

Appointed group controller as the business required stronger multi-site reporting.

Purchasing finance supervisor

Luyanshu Diagnostic Services

Sector
Clinical testing and laboratory support
Ownership
Founder-owned
Company scale
Approximately RMB68 million annual revenue at period end
Employees
One hundred and fifty-five at period end
Geography
China; original laboratory and a second site opened during the period
Reporting to
Financial controller; works with procurement manager
Team
Four purchasing and inventory-finance colleagues
Financial scope
Supplier comparisons, reagent commitments and equipment-related payment schedules

Mandate

Explain the full financial obligation of technically acceptable supply arrangements.

Outcomes

  • Compared purchase minima with supported consumption ranges
  • Included service and exit terms in equipment-related evaluations
  • Maintained a record of contractual commitments beyond current invoices

Decisions in context

I became responsible for the financial comparison of supply proposals that combined several different commitments. The laboratory and procurement teams identified technically acceptable options; I examined the prices, minimum purchases, payment timing and related service terms. A low initial cost could be attractive without being the least demanding arrangement over its stated period. I learnt to show the volume assumptions clearly and to distinguish purchased units from billable reports. My four colleagues maintained supplier and inventory schedules so that the comparison could be checked against actual activity later. I did not select a clinical method or decide whether a required control could be omitted. The role was valuable because it connected an understandable commercial document with the laboratory's practical requirements, allowing managers to negotiate a financial arrangement without losing sight of the professional service it had to support.

Reason for the move

Moved into commercial finance to connect the same cost understanding with customer terms.

Laboratory-cost accountant

Luyanshu Diagnostic Services

Sector
Independent diagnostic laboratory
Ownership
Founder-owned private business
Company scale
Approximately RMB29 million annual revenue at period end
Employees
Seventy-eight at period end
Geography
China; original laboratory
Reporting to
Financial controller
Team
Three-person accounting group; no direct reports
Financial scope
Assigned reagent, equipment and service-cost schedules

Mandate

Prepare cost explanations consistent with the laboratory's approved working process.

Outcomes

  • Separated material consumption from invoiced report counts
  • Documented the financial effect of required control and repeat activity
  • Prepared supported cost comparisons for controller review

Decisions in context

The laboratory director helped me understand why a cost schedule could be arithmetically correct and still invite the wrong conclusion. Some reagent use supported controls or necessary repeat work rather than another billable report. I learnt to ask how the approved process worked before describing a difference as waste or inefficiency. My task was to prepare schedules for the controller and retain the explanation supplied by the qualified team. I also became familiar with equipment-service costs and the way a supplier agreement could affect future expenditure. The appointment did not give me authority over clinical practice. It gave me a financial language that respected the purpose of the work being costed. That foundation made later discussions with procurement and commercial colleagues more productive because I could explain which assumptions were financial and which required a laboratory judgement.

Reason for the move

Promoted into purchasing finance after developing a detailed understanding of laboratory cost records.

Accounts officer, later inventory accountant

Xianruo Medical Supplies

Sector
Medical-consumables distribution
Ownership
Privately owned
Company scale
Approximately RMB22 million annual sales at period end
Employees
Sixty-two at period end
Geography
China; regional institutional customers
Reporting to
Chief accountant
Team
Five-person accounts office under the chief accountant
Financial scope
Supplier reconciliations, stock records and assigned customer accounts

Mandate

Keep the financial record supported by the relevant receipt, return and payment evidence.

Outcomes

  • Reconciled supplier statements to goods records
  • Separated return queries from routine payment differences
  • Prepared inventory schedules for authorised review

Decisions in context

I began with the records needed to explain what the company had bought, held and sold. Supplier statements had to agree with receipts and authorised returns, while customer accounts needed a clear reason for any unresolved amount. I worked under the chief accountant and prepared schedules for review rather than make commercial decisions myself. The business supplied medical consumables, but I was not a clinical adviser or a product-selection authority. I learnt to keep that boundary clear while understanding enough about the transaction to maintain an accurate account. An apparent payment difference could originate in a goods-return question that required another colleague's answer. By the end of the appointment, I wanted to understand how those supplies were used within a service. Moving into laboratory costing allowed me to connect the purchase record with a broader operating and financial explanation.

Reason for the move

Joined a laboratory business to develop experience with the service economics behind medical supplies.

What I am looking for next

An external appointment would interest me where the company needs to understand the financial support behind a specialist professional service. Healthcare-support businesses are a natural starting point, but I would need to learn the exact clinical, technical and legal responsibilities of any prospective organisation. I would seek a first audit or investment committee contribution under an experienced chair, rather than imply that my CFO role already makes me a board leader. Twenty-two days annually is an initial allowance subject to employer agreement and the actual work required. I would review relationships involving customers, suppliers, investors and advisers before committing. The contribution I hope to make is a disciplined explanation of commercial obligations and the costs of maintaining a dependable service, including transitions that do not immediately improve the annual result. I would also value directors who bring professional expertise outside finance and who expect me to listen before transferring a conclusion from the laboratory setting I know.